Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2016

01-08-2016 | Epidemiology

Effects of state-level medicaid policies and patient characteristics on time to breast cancer surgery among medicaid beneficiaries

Authors: Michael T. Halpern, Deborah Schrag

Published in: Breast Cancer Research and Treatment | Issue 3/2016

Login to get access

Abstract

Medicaid beneficiaries with cancer are less likely to receive timely and high-quality care. This study examined whether differences in state-level Medicaid policies affect delays in time to surgery (TTS) among women diagnosed with breast cancer. Using 2006–2008 Medicaid data, we identified women aged 18–64 enrolled in Medicaid diagnosed with breast cancer. Analyses examined associations of state-specific Medicaid surgery reimbursements, Medicaid eligibility recertification period (annually vs. shorter) and required patient copayment on time from breast cancer diagnosis to receipt of breast surgery. Patients receiving neoadjuvant therapy were excluded. Separate multivariable regression analyses controlling for patient demographic characteristics and clustering by state were performed for breast conserving surgery (BCS), inpatient mastectomy, and outpatient mastectomy. The study included 7542 Medicaid beneficiaries with breast cancer: 3272 received BCS, 2156 outpatient mastectomy, and 2115 inpatient mastectomy. Higher Medicaid reimbursements for BCS were associated with decreased time from diagnosis to surgery. A 12-month (vs. <12 month) Medicaid eligibility recertification period was associated with decreased TTS for BCS and outpatient mastectomy. Black Medicaid beneficiaries (compared with non-Hispanic White beneficiaries) were more likely to experience delays for all three types of surgery, while Hispanic beneficiaries were more likely to experience delays only for outpatient mastectomy. State-level Medicaid policies and patient characteristics can affect receipt of timely surgery among Medicaid beneficiaries with breast cancer. As delays in surgery can increase morbidity and mortality, changes to state Medicaid policies and health system programs are needed to improve access to care for this vulnerable population.
Literature
3.
go back to reference Coburn AF, Long SH, Marquis MS (1999) Effects of changing medicaid fees on physician participation and enrollee access. Inquiry 36:265–279PubMed Coburn AF, Long SH, Marquis MS (1999) Effects of changing medicaid fees on physician participation and enrollee access. Inquiry 36:265–279PubMed
4.
go back to reference Cohen JW, Cunningham PJ (1995) Medicaid physician fee levels and children’s access to care. Health Aff (Millwood) 14:255–262CrossRef Cohen JW, Cunningham PJ (1995) Medicaid physician fee levels and children’s access to care. Health Aff (Millwood) 14:255–262CrossRef
5.
go back to reference Cunningham PJ, Hadley J (2008) Effects of changes in incomes and practice circumstances on physicians’ decisions to treat charity and Medicaid patients. Milbank Q 86:91–123CrossRefPubMedPubMedCentral Cunningham PJ, Hadley J (2008) Effects of changes in incomes and practice circumstances on physicians’ decisions to treat charity and Medicaid patients. Milbank Q 86:91–123CrossRefPubMedPubMedCentral
6.
go back to reference Guy GP Jr (2010) The effects of cost sharing on access to care among childless adults. Health Serv Res 45:1720–1739CrossRefPubMed Guy GP Jr (2010) The effects of cost sharing on access to care among childless adults. Health Serv Res 45:1720–1739CrossRefPubMed
7.
go back to reference Resneck J Jr, Pletcher MJ, Lozano N (2004) Medicare, medicaid and access to dermatologists: the effect of patient insurance on appointment access and wait times. J Am Acad Dermatol 50:85–92CrossRefPubMed Resneck J Jr, Pletcher MJ, Lozano N (2004) Medicare, medicaid and access to dermatologists: the effect of patient insurance on appointment access and wait times. J Am Acad Dermatol 50:85–92CrossRefPubMed
9.
go back to reference Halpern MT, Romaire MA, Haber SG, Tangka FK, Sabatino SA, Howard DH (2014) Impact of state-specific Medicaid reimbursement and eligibility policies on receipt of cancer screening. Cancer 120(19):3016–3024CrossRefPubMedPubMedCentral Halpern MT, Romaire MA, Haber SG, Tangka FK, Sabatino SA, Howard DH (2014) Impact of state-specific Medicaid reimbursement and eligibility policies on receipt of cancer screening. Cancer 120(19):3016–3024CrossRefPubMedPubMedCentral
10.
go back to reference Bleicher RJ, Ruth K, Sigurdson ER, Beck JR, Ross E, Wong YN, Patel SA, Boraas M, Chang EI, Topham NS, Egleston BL (2016) Time to surgery and breast cancer survival in the United States. JAMA Oncol 2(3):330–339CrossRefPubMed Bleicher RJ, Ruth K, Sigurdson ER, Beck JR, Ross E, Wong YN, Patel SA, Boraas M, Chang EI, Topham NS, Egleston BL (2016) Time to surgery and breast cancer survival in the United States. JAMA Oncol 2(3):330–339CrossRefPubMed
11.
go back to reference Colleoni M, Bonetti M, Coates AS, Castiglione-Gertsch M, Gelber RD, Price K, Rudenstam CM, Lindtner J, Collins J, Thürlimann B, Holmberg S, Veronesi A, Marini G, Goldhirsch A (2000) Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group. J Clin Oncol 18(3):584–590PubMed Colleoni M, Bonetti M, Coates AS, Castiglione-Gertsch M, Gelber RD, Price K, Rudenstam CM, Lindtner J, Collins J, Thürlimann B, Holmberg S, Veronesi A, Marini G, Goldhirsch A (2000) Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group. J Clin Oncol 18(3):584–590PubMed
12.
go back to reference Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI (2006) Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Breast Cancer Res Treat 99(3):313–321CrossRefPubMed Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI (2006) Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Breast Cancer Res Treat 99(3):313–321CrossRefPubMed
13.
go back to reference Smith EC, Ziogas A, Anton-Culver H (2013) Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg 148(6):516–523CrossRefPubMed Smith EC, Ziogas A, Anton-Culver H (2013) Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg 148(6):516–523CrossRefPubMed
14.
go back to reference Chavez-MacGregor M, Clarke CA, Lichtensztajn DY, Giordano SH (2016) Delayed initiation of adjuvant chemotherapy among patients with breast cancer. JAMA Oncol 2(3):322–329CrossRefPubMed Chavez-MacGregor M, Clarke CA, Lichtensztajn DY, Giordano SH (2016) Delayed initiation of adjuvant chemotherapy among patients with breast cancer. JAMA Oncol 2(3):322–329CrossRefPubMed
15.
go back to reference Gagliato Dde M, Gonzalez-Angulo AM, Lei X, Theriault RL, Giordano SH, Valero V, Hortobagyi GN, Chavez-Macgregor M (2014) Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer. J Clin Oncol 32(8):735–744CrossRefPubMed Gagliato Dde M, Gonzalez-Angulo AM, Lei X, Theriault RL, Giordano SH, Valero V, Hortobagyi GN, Chavez-Macgregor M (2014) Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer. J Clin Oncol 32(8):735–744CrossRefPubMed
16.
go back to reference Wu XC, Lund MJ, Kimmick GG, Richardson LC, Sabatino SA, Chen VW, Fleming ST, Morris CR, Huang B, Trentham-Dietz A, Lipscomb J (2012) Influence of race, insurance, socioeconomic status and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers. J Clin Oncol 30(2):142–150CrossRefPubMed Wu XC, Lund MJ, Kimmick GG, Richardson LC, Sabatino SA, Chen VW, Fleming ST, Morris CR, Huang B, Trentham-Dietz A, Lipscomb J (2012) Influence of race, insurance, socioeconomic status and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers. J Clin Oncol 30(2):142–150CrossRefPubMed
17.
go back to reference Fedewa SA, Edge SB, Stewart AK, Halpern MT, Marlow NM, Ward EM (2011) Race and ethnicity are associated with delays in breast cancer treatment 2003–2006. J Health Care Poor Underserved 22(1):128–141PubMed Fedewa SA, Edge SB, Stewart AK, Halpern MT, Marlow NM, Ward EM (2011) Race and ethnicity are associated with delays in breast cancer treatment 2003–2006. J Health Care Poor Underserved 22(1):128–141PubMed
18.
go back to reference Mosunjac M, Park J, Strauss A, Birdsong G, Du V, Rizzo M, Gabram SG, Lund MJ (2012) Time to treatment for patients receiving BCS in a public and a private university hospital in Atlanta. Breast J 18(2):163–167CrossRefPubMed Mosunjac M, Park J, Strauss A, Birdsong G, Du V, Rizzo M, Gabram SG, Lund MJ (2012) Time to treatment for patients receiving BCS in a public and a private university hospital in Atlanta. Breast J 18(2):163–167CrossRefPubMed
19.
go back to reference Ward E, Halpern M, Schrag N, Cokkinides V, DeSantis C, Bandi P, Siegel R, Stewart A, Jemal A (2008) Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin 58(1):9–31CrossRefPubMed Ward E, Halpern M, Schrag N, Cokkinides V, DeSantis C, Bandi P, Siegel R, Stewart A, Jemal A (2008) Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin 58(1):9–31CrossRefPubMed
20.
go back to reference Elmore JG, Nakano CY, Linden HM, Reisch LM, Ayanian JZ, Larson EB (2005) Racial inequities in the timing of breast cancer detection, diagnosis and initiation of treatment. Med Care 43(2):141–148CrossRefPubMed Elmore JG, Nakano CY, Linden HM, Reisch LM, Ayanian JZ, Larson EB (2005) Racial inequities in the timing of breast cancer detection, diagnosis and initiation of treatment. Med Care 43(2):141–148CrossRefPubMed
21.
go back to reference Gorin SS, Heck JE, Cheng B, Smith SJ (2006) Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med 166(20):2244–2252CrossRefPubMed Gorin SS, Heck JE, Cheng B, Smith SJ (2006) Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med 166(20):2244–2252CrossRefPubMed
22.
go back to reference Gwyn K, Bondy ML, Cohen DS, Lund MJ, Liff JM, Flagg EW, Brinton LA, Eley JW, Coates RJ (2004) Racial differences in diagnosis, treatment and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer 100(8):1595–1604CrossRefPubMed Gwyn K, Bondy ML, Cohen DS, Lund MJ, Liff JM, Flagg EW, Brinton LA, Eley JW, Coates RJ (2004) Racial differences in diagnosis, treatment and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer 100(8):1595–1604CrossRefPubMed
23.
go back to reference Kroenke CH, Rosner B, Chen WY, Kawachi I, Colditz GA, Holmes MD (2004) Functional impact of breast cancer by age at diagnosis. J Clin Oncol 22(10):1849–1856CrossRefPubMed Kroenke CH, Rosner B, Chen WY, Kawachi I, Colditz GA, Holmes MD (2004) Functional impact of breast cancer by age at diagnosis. J Clin Oncol 22(10):1849–1856CrossRefPubMed
24.
go back to reference Rosenberg SM, Newman LA, Partridge AH (2015) Breast cancer in young women: rare disease or public health problem? JAMA Oncol 1(7):877–878CrossRefPubMed Rosenberg SM, Newman LA, Partridge AH (2015) Breast cancer in young women: rare disease or public health problem? JAMA Oncol 1(7):877–878CrossRefPubMed
25.
go back to reference Koroukian SM, Cooper GS, Rimm AA (2003) Ability of medicaid claims data to identify incident cases of breast cancer in the ohio medicaid population. Health Serv Res 38(3):947–960CrossRefPubMedPubMedCentral Koroukian SM, Cooper GS, Rimm AA (2003) Ability of medicaid claims data to identify incident cases of breast cancer in the ohio medicaid population. Health Serv Res 38(3):947–960CrossRefPubMedPubMedCentral
26.
go back to reference Nattinger AB, Laud PW, Bajorunaite R, Sparapani RA, Freeman JL (2004) An algorithm for the use of medicare claims data to identify women with incident breast cancer. Health Serv Res 39(6 Pt 1):1733–1749CrossRefPubMedPubMedCentral Nattinger AB, Laud PW, Bajorunaite R, Sparapani RA, Freeman JL (2004) An algorithm for the use of medicare claims data to identify women with incident breast cancer. Health Serv Res 39(6 Pt 1):1733–1749CrossRefPubMedPubMedCentral
27.
go back to reference Warren JL, Feuer E, Potosky AL, Riley GF, Lynch CF (1999) Use of medicare hospital and physician data to assess breast cancer incidence. Med Care 37(5):445–456CrossRefPubMed Warren JL, Feuer E, Potosky AL, Riley GF, Lynch CF (1999) Use of medicare hospital and physician data to assess breast cancer incidence. Med Care 37(5):445–456CrossRefPubMed
30.
go back to reference Sommers BD, Rosenbaum S (2011) Issues in health reform: how changes in eligibility may move millions back and forth between medicaid and insurance exchanges. Health Aff (Millwood) 30(2):228–236CrossRef Sommers BD, Rosenbaum S (2011) Issues in health reform: how changes in eligibility may move millions back and forth between medicaid and insurance exchanges. Health Aff (Millwood) 30(2):228–236CrossRef
31.
go back to reference Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45(6):613–619CrossRefPubMed Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45(6):613–619CrossRefPubMed
32.
go back to reference Asplin BR, Rhodes KV, Levy H, Lurie N, Crain AL, Carlin BP, Kellermann AL (2005) Insurance status and access to urgent ambulatory care follow-up appointments. JAMA 294(10):1248–1254CrossRefPubMed Asplin BR, Rhodes KV, Levy H, Lurie N, Crain AL, Carlin BP, Kellermann AL (2005) Insurance status and access to urgent ambulatory care follow-up appointments. JAMA 294(10):1248–1254CrossRefPubMed
33.
go back to reference Hall AG, Lemak CH, Steingraber H, Schaffer S (2008) Expanding the definition of access: it isn’t just about health insurance. J Health Care Poor Underserved 19(2):625–638CrossRefPubMed Hall AG, Lemak CH, Steingraber H, Schaffer S (2008) Expanding the definition of access: it isn’t just about health insurance. J Health Care Poor Underserved 19(2):625–638CrossRefPubMed
34.
go back to reference Resneck JS Jr, Isenstein A, Kimball AB (2006) Few medicaid and uninsured patients are accessing dermatologists. J Am Acad Dermatol 55(6):1084–1088CrossRefPubMed Resneck JS Jr, Isenstein A, Kimball AB (2006) Few medicaid and uninsured patients are accessing dermatologists. J Am Acad Dermatol 55(6):1084–1088CrossRefPubMed
35.
go back to reference Dall TM, Storm MV, Chakrabarti R, Drogan O, Keran CM, Donofrio PD, Henderson VW, Kaminski HJ, Stevens JC, Vidic TR (2013) Supply and demand analysis of the current and future US neurology workforce. Neurology 81(5):470–478CrossRefPubMedPubMedCentral Dall TM, Storm MV, Chakrabarti R, Drogan O, Keran CM, Donofrio PD, Henderson VW, Kaminski HJ, Stevens JC, Vidic TR (2013) Supply and demand analysis of the current and future US neurology workforce. Neurology 81(5):470–478CrossRefPubMedPubMedCentral
Metadata
Title
Effects of state-level medicaid policies and patient characteristics on time to breast cancer surgery among medicaid beneficiaries
Authors
Michael T. Halpern
Deborah Schrag
Publication date
01-08-2016
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2016
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-016-3879-8

Other articles of this Issue 3/2016

Breast Cancer Research and Treatment 3/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine